Castle Biosciences Inc. (CSTL)
NASDAQ: CSTL
· Real-Time Price · USD
22.71
-0.03 (-0.13%)
At close: Sep 26, 2025, 3:59 PM
22.71
0.00%
After-hours: Sep 26, 2025, 04:28 PM EDT
Castle Biosciences Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dermatologic Revenue | 56.3M | 62.96M | 63.77M | 65.06M | 68.83M | 59.33M | 53.28M | 51.15M | 43.03M | 35.91M | 34.65M | 33.92M | 31.9M | 24.34M |
| Dermatologic Revenue Growth | -10.59% | -1.27% | -1.98% | -5.47% | +16.00% | +11.36% | +4.17% | +18.87% | +19.82% | +3.64% | +2.14% | +6.35% | +31.05% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 58.06M | 58.62M | 49.97M | 50.5M | 50.71M | 48.41M | 43.77M | 44.62M | 44.68M | 46.76M | 38.43M | 36.63M | 37.5M | 30.45M | 25.16M | 22.59M | 20.82M | 18.16M | 14.96M | 11.7M | 10.39M | 11.08M | 9.85M | 7.12M | 6.82M | 6.05M | 4.16M | 3.92M | 4.16M | 4.23M |
| Selling, General, and Administrative Revenue Growth | -0.95% | +17.32% | -1.06% | -0.41% | +4.75% | +10.59% | -1.89% | -0.14% | -4.45% | +21.69% | +4.91% | -2.33% | +23.13% | +21.04% | +11.35% | +8.52% | +14.65% | +21.41% | +27.82% | +12.62% | -6.19% | +12.44% | +38.33% | +4.41% | +12.81% | +45.20% | +6.28% | -5.80% | -1.61% | n/a |
| Research and Development Revenue | 12.79M | 12.59M | 11.68M | 12.32M | 14.05M | 13.46M | 12.91M | 12.92M | 13.31M | 14.39M | 11.31M | 10.91M | 11.93M | 10.76M | 9.45M | 7.5M | 6.79M | 5.91M | 4.58M | 3.06M | 2.7M | 2.91M | 3.16M | 1.51M | 1.32M | 1.39M | 1.14M | 1.29M | 1.16M | 1.26M |
| Research and Development Revenue Growth | +1.58% | +7.80% | -5.24% | -12.30% | +4.43% | +4.22% | -0.10% | -2.89% | -7.54% | +27.27% | +3.69% | -8.54% | +10.83% | +13.93% | +25.93% | +10.41% | +14.98% | +28.97% | +49.80% | +13.09% | -7.17% | -7.79% | +108.52% | +15.01% | -5.50% | +22.48% | -12.07% | +11.65% | -8.20% | n/a |